|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Adenosine Deaminase, RBC
Test Code39148
CPT Codes
82657<br /> This test is not available for New York patient testing
Preferred Specimen
1 mL whole blood collected in an EDTA (lavender-top or pink-top) or sodium or lithium heparin (green top) tube
Minimum Volume
1 mL
Transport Temperature
Room temperature
Specimen Stability
Room temperature: 15 days
Refrigerated: 15 days
Frozen: Unacceptable
Refrigerated: 15 days
Frozen: Unacceptable
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Hemolysis
Methodology
Kinetic Spectrophotometry
FDA Status
Test developed and characteristics determined by ARUP Laboratories.
Setup Schedule
Tuesday, Thursday, Sunday Morning
Report available: 2 Days
Report available: 2 Days
Reference Range
400-900 mU/g Hb
Clinical Significance
Adenosine Deaminase (ADA) deficiency is an autosomal recessive disorder of purine metabolism primarily affecting lymphocyte development, viability, and function. Affected individuals have less than 1 percent of normal ADA catalytic activity in red cell hemolysates. ADA deficiency is the cause of 20-30 percent of SCID cases. If the patient has been recently transfused, ADA deficiency may be masked; interpret results with caution. Heterozygotes cannot be identified by this test.